IRES-dependent replication of Venezuelan equine encephalitis virus makes it highly attenuated and incapable of replicating in mosquito cells

Virology

Volumn 377, Issue 1, 2008, Pages 160-169

  Volkova, Eugenia ^a   Frolova, Elena ^a   Darwin, Justin R ^a   Forrester, Naomi L ^a   Weaver, Scott C ^a   Frolov, Ilya ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Alphavirus; EMCV IRES; Mosquito cells; Replication; VEEV

Indexed keywords

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC ANALYSIS; MOLECULAR CLONING; MOSQUITO; MOUSE; MUTATIONAL ANALYSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VENEZUELAN EQUINE ENCEPHALOMYELITIS ALPHAVIRUS; VENEZUELAN EQUINE ENCEPHALOMYELITIS ALPHAVIRUS TC 83; VIRUS RECOMBINANT; VIRUS REPLICATION;

ADAPTATION, PHYSIOLOGICAL; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CELL LINE; CRICETINAE; CULICIDAE; ENCEPHALITIS VIRUS, VENEZUELAN EQUINE; MICE; MUTATION; NIH 3T3 CELLS; PHENOTYPE; RECOMBINATION, GENETIC; RNA, VIRAL; VIRAL NONSTRUCTURAL PROTEINS; VIRULENCE; VIRUS REPLICATION;

ALPHAVIRUS; ENCEPHALOMYOCARDITIS VIRUS; HEXAPODA; MUS; VENEZUELAN EQUINE ENCEPHALITIS VIRUS; VERTEBRATA;

EID: 44949123428     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2008.04.020     Document Type: Article

References (47)

1. Aguilar P.V., Weaver S.C., and Basler C.F. Capsid protein of eastern equine encephalitis virus inhibits host cell gene expression. J. Virol. 81 8 (2007) 3866-3876
2. Alevizatos A.C., McKinney R.W., and Feigin R.D. Live, attenuated Venezuelan equine encephalomyelitis virus vaccine. I. Clinical effects in man. Am. J. Trop. Med. Hyg. 16 6 (1967) 762-768
3. Barton D.J., Morasco B.J., and Flanegan J.B. Translating ribosomes inhibit poliovirus negative-strand RNA synthesis. J. Virol. 73 12 (1999) 10104-10112
4. Berge T.O., Banks I.S., and Tigertt W.D. Attenuation of Venezuelan equine encephalomyelitis virus by in vitro cultivation in guinea pig heart cells. Am. J. Hyg. 73 (1961) 209-218
5. Blaney Jr. J.E., Matro J.M., Murphy B.R., and Whitehead S.S. Recombinant, live-attenuated tetravalent dengue virus vaccine formulations induce a balanced, broad, and protective neutralizing antibody response against each of the four serotypes in rhesus monkeys. J. Virol. 79 9 (2005) 5516-5528
6. Blaney Jr. J.E., Durbin A.P., Murphy B.R., and Whitehead S.S. Development of a live attenuated dengue virus vaccine using reverse genetics. Viral. Immunol. 19 1 (2006) 10-32
7. Brault A.C., Powers A.M., Ortiz D., Estrada-Franco J.G., Navarro-Lopez R., and Weaver S.C. Venezuelan equine encephalitis emergence: enhanced vector infection from a single amino acid substitution in the envelope glycoprotein. Proc. Natl. Acad. Sci. U. S. A. 101 31 (2004) 11344-11349
8. Bredenbeek P.J., Frolov I., Rice C.M., and Schlesinger S. Sindbis virus expression vectors: packaging of RNA replicons by using defective helper RNAs. J. Virol. 67 (1993) 6439-6446
9. Burke D.S., Ramsburg H.H., and Edelman R. Persistence in humans of antibody to subtypes of Venezuelan equine encephalomyelitis (VEE) virus after immunization with attenuated (TC-83) VEE virus vaccine. J. Infect. Dis. 136 3 (1977) 354-359
10. Dal Canto M.C., and Rabinowitz S.G. Central nervous system demyelination in Venezuelan equine encephalomyelitis infection. J. Neurol. Sci. 49 3 (1981) 397-418
11. Davis N.L., Willis L.V., Smith J.F., and Johnston R.E. In vitro synthesis of infectious Venezuelan equine encephalitis virus RNA from a cDNA clone: analysis of a viable deletion mutant. Virology 171 (1989) 189-204
12. Davis N.L., Powell N., Greenwald G.F., Willis L.V., Johnson B.J.B., Smith J.F., and Johnston R.E. Attenuating mutations in the E2 glycoprotein gene of Venezuelan equine encephalitis: construction of single and multiple mutants in a full-length clone. Virology 183 (1991) 20-31
13. Davis N.L., Brown K.W., Greenwald G.F., Zajac A.J., Zacny V.L., Smith J.F., and Johnston R.E. Attenuated mutants of Venezuelan equine encephalitis virus containing lethal mutations in the PE2 cleavage signal combined with a second-site suppressor mutation in E1. Virology 212 1 (1995) 102-110
14. Finkelstein Y., Faktor O., Elroy-Stein O., and Levi B.Z. The use of bi-cistronic transfer vectors for the baculovirus expression system. J. Biotechnol. 75 1 (1999) 33-44
15. Garmashova N., Gorchakov R., Frolova E., and Frolov I. Sindbis virus nonstructural protein nsP2 is cytotoxic and inhibits cellular transcription. J. Virol. 80 12 (2006) 5686-5696
16. Garmashova N., Atasheva S., Kang W., Weaver S.C., Frolova E., and Frolov I. Analysis of Venezuelan equine encephalitis virus capsid protein function in the inhibition of cellular transcription. J. Virol. 81 24 (2007) 13552-13565
17. Garmashova N., Gorchakov R., Volkova E., Paessler S., Frolova E., and Frolov I. The Old World and New World alphaviruses use different virus-specific proteins for induction of transcriptional shutoff. J. Virol. 81 5 (2007) 2472-2484
18. Gorchakov R., Hardy R., Rice C.M., and Frolov I. Selection of functional 5′ cis-acting elements promoting efficient sindbis virus genome replication. J. Virol. 78 1 (2004) 61-75
19. Gorchakov R., Volkova E., Yun N., Petrakova O., Linde N.S., Paessler S., Frolova E., and Frolov I. Comparative analysis of the alphavirus-based vectors expressing Rift Valley fever virus glycoproteins. Virology 366 1 (2007) 212-225
20. Griffin D.E. Alphaviruses. In: Knipe D.M., and Howley P.M. (Eds). Fields' Virology. Fourth Edition (2001), Lippincott, Williams and Wilkins, New York 917-962
21. Hart M.K., Caswell-Stephan K., Bakken R., Tammariello R., Pratt W., Davis N., Johnston R.E., Smith J., and Steele K. Improved mucosal protection against Venezuelan equine encephalitis virus is induced by the molecularly defined, live-attenuated V3526 vaccine candidate. Vaccine 18 26 (2000) 3067-3075
22. Jan E., and Sarnow P. Factorless ribosome assembly on the internal ribosome entry site of cricket paralysis virus. J. Mol. Biol. 324 5 (2002) 889-902
23. Johnson K.M., and Martin D.H. Venezuelan equine encephalitis. Adv. Vet. Sci. Comp. Med. 18 (1974) 79-116
24. Khromykh A.A., Varnavski A.N., Sedlak P.L., and Westaway E.G. Coupling between replication and packaging of flavivirus RNA: evidence derived from the use of DNA-based full-length cDNA clones of Kunjin virus. J. Virol. 75 10 (2001) 4633-4640
25. Kinney R.M., Chang G.-J., Tsuchiya K.R., Sneider J.M., Roehrig J.T., Woodward T.M., and Trent D.W. Attenuation of Venezuelan equine encephalitis virus strain TC-83 is encoded by the 5′-non coding region and the E2 envelope glycoprotein. J. Virol. 67 (1993) 1269-1277
26. Kinney R.M., Johnson B.J.B., Welch J.B., Tsuchiya K.R., and Trent D.W. The full-length nucleotide sequences of the virulent Trinidad donkey strain of Venezuelan equine encephalitis virus and its attenuated vaccine derivative, strain TC-83. Virology 170 (1989) 19-30
27. Kuhn R.J., Griffin D.E., Owen K.E., Niesters H.G., and Strauss J.H. Chimeric Sindbis-Ross River viruses to study interactions between alphavirus nonstructural and structural regions. J. Virol. 70 11 (1996) 7900-7909
28. Lemm J.A., Durbin R.K., Stollar V., and Rice C.M. Mutations which alter the level or structure of nsP4 can affect the efficiency of Sindbis virus replication in a host-dependent manner. J. Virol. 64 (1990) 3001-3011
29. Liljeström P., Lusa S., Huylebroeck D., and Garoff H. In vitro mutagenesis of a full-length cDNA clone of Semliki Forest virus: the small 6000-molecular-weight membrane protein modulates virus release. J. Virol. 65 (1991) 4107-4113
30. Morrill J.C., Carpenter L., Taylor D., Ramsburg H.H., Quance J., and Peters C.J. Further evaluation of a mutagen-attenuated Rift Valley fever vaccine in sheep. Vaccine 9 1 (1991) 35-41
31. Murphy B.R., and Chanock R.M. Immunization against viral diseases. In: Knipe D.M., and Howley P.M. (Eds). Fields' Virology. Fourth Edition (2001), Lippincott, Williams and Wilkins, New York 435-467
32. Nugent C.I., Johnson K.L., Sarnow P., and Kirkegaard K. Functional coupling between replication and packaging of poliovirus replicon RNA. J. Virol. 73 1 (1999) 427-435
33. Paessler S., Fayzulin R.Z., Anishchenko M., Greene I.P., Weaver S.C., and Frolov I. Recombinant sindbis/Venezuelan equine encephalitis virus is highly attenuated and immunogenic. J. Virol. 77 17 (2003) 9278-9286
34. Pedersen Jr. C.E., Robinson D.M., and Cole Jr. F.E. Isolation of the vaccine strain of Venezuelan equine encephalomyelitis virus from mosquitoes in Louisiana. Am. J. Epidemiol. 95 5 (1972) 490-496
35. Petrakova O., Volkova E., Gorchakov R., Paessler S., Kinney R.M., and Frolov I. Noncytopathic replication of Venezuelan equine encephalitis virus and eastern equine encephalitis virus replicons in mammalian cells. J. Virol. 79 12 (2005) 7597-7608
36. Pittman P.R., Makuch R.S., Mangiafico J.A., Cannon T.L., Gibbs P.H., and Peters C.J. Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine. Vaccine 14 4 (1996) 337-343
37. Pugachev K.V., Tzeng W.P., and Frey T.K. Development of a rubella virus vaccine expression vector: use of a picornavirus internal ribosome entry site increases stability of expression. J. Virol. 74 22 (2000) 10811-10815
38. Rice C.M., Levis R., Strauss J.H., and Huang H.V. Production of infectious RNA transcripts from Sindbis virus cDNA clones: mapping of lethal mutations, rescue of a temperature-sensitive marker, and in vitro mutagenesis to generate defined mutants. J. Virol. 61 12 (1987) 3809-3819
39. Rivas F., Diaz L.A., Cardenas V.M., Daza E., Bruzon L., Alcala A., De la Hoz O., Caceres F.M., Aristizabal G., Martinez J.W., Revelo D., De la Hoz F., Boshell J., Camacho T., Calderon L., Olano V.A., Villarreal L.I., Roselli D., Alvarez G., Ludwig G., and Tsai T. Epidemic Venezuelan equine encephalitis in La Guajira, Colombia, 1995. J. Infect. Dis. 175 4 (1997) 828-832
40. Russo A.T., White M.A., and Watowich S.J. The crystal structure of the Venezuelan equine encephalitis alphavirus nsP2 protease. Structure 14 9 (2006) 1449-1458
41. Strauss J.H., and Strauss E.G. The alphaviruses: gene expression, replication, evolution. Microbiol. Rev. 58 (1994) 491-562
42. Thomas J.M., Klimstra W.B., Ryman K.D., and Heidner H.W. Sindbis virus vectors designed to express a foreign protein as a cleavable component of the viral structural polyprotein. J. Virol. 77 10 (2003) 5598-5606
43. Trgovcich J., Aronson J.F., and Johnston R.E. Fatal Sindbis virus infection of neonatal mice in the absence of encephalitis. Virology 224 1 (1996) 73-83
44. Tsetsarkin K.A., Vanlandingham D.L., McGee C.E., and Higgs S. A single mutation in chikungunya virus affects vector specificity and epidemic potential. PLoS Pathog. 3 12 (2007) e201
45. Weaver S.C. Vector biology in viral pathogenesis. In: Nathanson N. (Ed). Viral Pathogenesis (1997), Lippincott-Raven, New York 329-352
46. White L.J., Wang J.G., Davis N.L., and Johnston R.E. Role of alpha/beta interferon in Venezuelan equine encephalitis virus pathogenesis: effect of an attenuating mutation in the 5′ untranslated region. J. Virol. 75 8 (2001) 3706-3718
47. Woolaway K.E., Lazaridis K., Belsham G.J., Carter M.J., and Roberts L.O. The 5′ untranslated region of Rhopalosiphum padi virus contains an internal ribosome entry site which functions efficiently in mammalian, plant, and insect translation systems. J. Virol. 75 21 (2001) 10244-10249